Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14948 | 671 | 21.8 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
82 | 26468 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EPIDEMIOLOGY OF TUBERCULOSIS | Author keyword | 2 | 67% | 0% | 2 |
2 | RENAL ALLOGRAFT RECIPIENT | Author keyword | 2 | 40% | 1% | 4 |
3 | TUBERCULOUS PERITONITIS | Author keyword | 2 | 14% | 2% | 12 |
4 | BUREAU S | Address | 1 | 50% | 0% | 1 |
5 | CANDIDATE SCREENING | Author keyword | 1 | 50% | 0% | 1 |
6 | CHRONIC VENAL FAILURE | Author keyword | 1 | 50% | 0% | 1 |
7 | CONSULTAT CHIRURG | Address | 1 | 50% | 0% | 1 |
8 | CPAP DEVICES | Author keyword | 1 | 50% | 0% | 1 |
9 | DERMATOL IMMACOLATA | Address | 1 | 50% | 0% | 1 |
10 | EA3287 IFR125 | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSTTRANSPLANT TUBERCULOSIS | 34 | 93% | 2% | 13 |
2 | MYCOBACTERIAL INFECTIONS | 10 | 29% | 4% | 28 |
3 | ISONIAZID CHEMOPROPHYLAXIS | 6 | 39% | 2% | 12 |
4 | DIALYSIS AWAITING TRANSPLANTATION | 2 | 67% | 0% | 2 |
5 | ISONIAZID HEPATOTOXICITY | 1 | 27% | 1% | 4 |
6 | ADOLESCENT TUBERCULOSIS | 1 | 50% | 0% | 1 |
7 | ADVANCED PULMONARY TUBERCULOSIS | 1 | 50% | 0% | 1 |
8 | CHILDRENS HOSPITAL EXPERIENCE | 1 | 50% | 0% | 1 |
9 | INACTIVE TUBERCULOSIS | 1 | 50% | 0% | 1 |
10 | LATE CYTOMEGALOVIRUS DISEASE | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management | 1998 | 231 | 82 | 79% |
Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis | 2010 | 23 | 65 | 69% |
Mycobacterial infections in solid organ transplant recipients | 2014 | 3 | 95 | 60% |
Mycobacterium tuberculosis Infection in Liver Transplantation | 2010 | 15 | 23 | 74% |
Tuberculosis in solid organ transplant candidates and recipients: current and future challenges | 2014 | 3 | 40 | 48% |
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement | 2012 | 28 | 146 | 28% |
Tuberculosis in Liver Transplant Recipients: A Systematic Review and Meta-Analysis of Individual Patient Data | 2009 | 37 | 89 | 45% |
Mycobacterium tuberculous peritonitis in CAPD patients: a report of 11 patients and review of literature | 2013 | 3 | 26 | 81% |
Treating tuberculosis in solid organ transplant recipients | 2014 | 1 | 38 | 74% |
Tuberculosis in hematopoietic stem cell transplant patients: case report and review of the literature | 2010 | 9 | 20 | 70% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BUREAU S | 1 | 50% | 0.1% | 1 |
2 | CONSULTAT CHIRURG | 1 | 50% | 0.1% | 1 |
3 | DERMATOL IMMACOLATA | 1 | 50% | 0.1% | 1 |
4 | EA3287 IFR125 | 1 | 50% | 0.1% | 1 |
5 | HOSP CLIN UNIV VIRGEN ARRIXACA | 1 | 50% | 0.1% | 1 |
6 | HOSP UNIV DOCE DE OCTUBRE | 1 | 50% | 0.1% | 1 |
7 | INTERNAL MEDECINE | 1 | 50% | 0.1% | 1 |
8 | MED PREVENT CONTROL INFECT DIS | 1 | 50% | 0.1% | 1 |
9 | NEPHROL CRIT CARE NEPHROL | 1 | 50% | 0.1% | 1 |
10 | PROGRAMA POS MESTRADO ENFERMAGEM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141024 | TUBERCULIN SKIN TEST//INTERFERON GAMMA RELEASE ASSAY//T SPOTTB |
2 | 0.0000127913 | ISONIAZID//DRUG REASSESSMENT//DRUG INDUCED HEPATOTOXICITY |
3 | 0.0000124997 | TRANSPLANT MED NEPHROL//GRAM NEGATIVE BACILLUS//SURG NURSING TRANSPLANTAT |
4 | 0.0000107563 | MED PSYCHIAT DRUG ADDICT UNIT//ISONIAZID INTOXICATION//ZIPEPROL |
5 | 0.0000103759 | ENDOBRONCHIAL TUBERCULOSIS//MILIARY TUBERCULOSIS//LOWER LUNG FIELD TUBERCULOSIS |
6 | 0.0000103469 | PASS//COMMUNITY ACQUIRED INFECTIOUS DISEASES//PPD TUBERCULIN |
7 | 0.0000097949 | ABDOMINAL TUBERCULOSIS//PERITONEAL TUBERCULOSIS//INTESTINAL TUBERCULOSIS |
8 | 0.0000094752 | HIGH RISK DONOR//DONOR DERIVED INFECTION//DONOR TO HOST TRANSMISSION |
9 | 0.0000079687 | INTRACARDIAC TUBERCULOMA//MALARIA ENDEMIC REGION//MSR NAGAR |
10 | 0.0000067619 | GENITOURINARY TUBERCULOSIS//UROGENITAL TUBERCULOSIS//RENAL TUBERCULOSIS |